Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 88 entries
Sorted by: Best Match Show Resources per page
NetMatchStar: an enhanced Cytoscape network querying app.

F1000Research

Rinnone F, Micale G, Bonnici V, Bader GD, Shasha D, Ferro A, Pulvirenti A, Giugno R.
PMID: 26594341
F1000Res. 2015 Aug 05;4:479. doi: 10.12688/f1000research.6656.1. eCollection 2015.

We present NetMatchStar, a Cytoscape app to find all the occurrences of a query graph in a network and check for its significance as a motif with respect to seven different random models. The query can be uploaded or...

Cite
Rinnone F, Micale G, Bonnici V, et al. NetMatchStar: an enhanced Cytoscape network querying app. F1000Res. 2015;4:479doi: 10.12688/f1000research.6656.1.
Rinnone, F., Micale, G., Bonnici, V., Bader, G. D., Shasha, D., Ferro, A., Pulvirenti, A., & Giugno, R. (2015). NetMatchStar: an enhanced Cytoscape network querying app. F1000Research, 4479. https://doi.org/10.12688/f1000research.6656.1
Rinnone, Fabio, et al. "NetMatchStar: an enhanced Cytoscape network querying app." F1000Research vol. 4 (2015): 479. doi: https://doi.org/10.12688/f1000research.6656.1
Rinnone F, Micale G, Bonnici V, Bader GD, Shasha D, Ferro A, Pulvirenti A, Giugno R. NetMatchStar: an enhanced Cytoscape network querying app. F1000Res. 2015 Aug 05;4:479. doi: 10.12688/f1000research.6656.1. eCollection 2015. PMID: 26594341; PMCID: PMC4642848.
Copy Download .nbib Format: NLM
Low-Dose Aspirin and Ibuprofen Reduce the Cutaneous Reactions Following Niacin Administration.

American journal of therapeutics

Dunn RT, Ford MA, Rindone JP, Kwiecinski FA.
PMID: 11850694
Am J Ther. 1995 Jul;2(7):478-480. doi: 10.1097/00045391-199506000-00006.

BACKGROUND: Moderate doses of prostaglandin inhibitors may reduce the cutaneous reactions from niacin administration. We undertook this study to determine if low doses of either ibuprofen or aspirin reduces cutaneous reactions from niacin in healthy volunteers. METHODS: Twenty-two subjects...

Cite
Dunn RT, Ford MA, Rindone JP, et al. Low-Dose Aspirin and Ibuprofen Reduce the Cutaneous Reactions Following Niacin Administration. Am J Ther. 1995;2(7):478-480doi: 10.1097/00045391-199506000-00006.
Dunn, R. T., Ford, M. A., Rindone, J. P., & Kwiecinski, F. A. (1995). Low-Dose Aspirin and Ibuprofen Reduce the Cutaneous Reactions Following Niacin Administration. American journal of therapeutics, 2(7), 478-480. https://doi.org/10.1097/00045391-199506000-00006
Dunn, Raymond T., et al. "Low-Dose Aspirin and Ibuprofen Reduce the Cutaneous Reactions Following Niacin Administration." American journal of therapeutics vol. 2,7 (1995): 478-480. doi: https://doi.org/10.1097/00045391-199506000-00006
Dunn RT, Ford MA, Rindone JP, Kwiecinski FA. Low-Dose Aspirin and Ibuprofen Reduce the Cutaneous Reactions Following Niacin Administration. Am J Ther. 1995 Jul;2(7):478-480. doi: 10.1097/00045391-199506000-00006. PMID: 11850694.
Copy Download .nbib Format: NLM
[Medico-social problems concerning children with poliomyelitis].

Boletin medico del Hospital Infantil de Mexico

RINCON E.
PMID: 13140439
Bol Med Hosp Infant Mex. 1953 Dec 01;10(6):718-21.

No abstract available.

Cite
RINCON E. Problemas médico-sociales de los niños con poliomielitis. [Medico-social problems concerning children with poliomyelitis]. Bol Med Hosp Infant Mex. 1953;10(6):718-21
RINCON, E. (1953). Problemas médico-sociales de los niños con poliomielitis. [Medico-social problems concerning children with poliomyelitis]. Boletin medico del Hospital Infantil de Mexico, 10(6), 718-21.
RINCON, E. "Problemas médico-sociales de los niños con poliomielitis." [Medico-social problems concerning children with poliomyelitis]. Boletin medico del Hospital Infantil de Mexico vol. 10,6 (1953): 718-21.
RINCON E. Problemas médico-sociales de los niños con poliomielitis. [Medico-social problems concerning children with poliomyelitis]. Bol Med Hosp Infant Mex. 1953 Dec 01;10(6):718-21. Undetermined. PMID: 13140439.
Copy Download .nbib Format: NLM
[ARETAEUS of Cappadocia, the earliest phthisiologist].

Minerva medica

RANDONE M.
PMID: 13972993
Minerva Med. 1963 Mar 14;54:Varia 358-60.

No abstract available.

Cite
RANDONE M. [ARETAEUS of Cappadocia, the earliest phthisiologist]. Minerva Med. 1963;54:Varia 358-60
RANDONE, M. (1963). [ARETAEUS of Cappadocia, the earliest phthisiologist]. Minerva medica, 54Varia 358-60.
RANDONE, M. "[ARETAEUS of Cappadocia, the earliest phthisiologist]." Minerva medica vol. 54 (1963): Varia 358-60.
RANDONE M. [ARETAEUS of Cappadocia, the earliest phthisiologist]. Minerva Med. 1963 Mar 14;54:Varia 358-60. Italian. PMID: 13972993.
Copy Download .nbib Format: NLM
[TRAVELS AND ITINERARIES OF LAZZARO SPALLANZANI].

Minerva medica

RANDONE M.
PMID: 14174112
Minerva Med. 1964 Jun 23;55:869-82.

No abstract available.

Cite
RANDONE M. VIAGGI E ITINERARI DI LAZZARO SPALLANZANI. [TRAVELS AND ITINERARIES OF LAZZARO SPALLANZANI]. Minerva Med. 1964;55:869-82
RANDONE, M. (1964). VIAGGI E ITINERARI DI LAZZARO SPALLANZANI. [TRAVELS AND ITINERARIES OF LAZZARO SPALLANZANI]. Minerva medica, 55869-82.
RANDONE, M. "VIAGGI E ITINERARI DI LAZZARO SPALLANZANI." [TRAVELS AND ITINERARIES OF LAZZARO SPALLANZANI]. Minerva medica vol. 55 (1964): 869-82.
RANDONE M. VIAGGI E ITINERARI DI LAZZARO SPALLANZANI. [TRAVELS AND ITINERARIES OF LAZZARO SPALLANZANI]. Minerva Med. 1964 Jun 23;55:869-82. Italian. PMID: 14174112.
Copy Download .nbib Format: NLM
Tuning ion channel mechanosensitivity by asymmetry of the transbilayer pressure profile.

Biophysical reviews

Martinac B, Bavi N, Ridone P, Nikolaev YA, Martinac AD, Nakayama Y, Rohde PR, Bavi O.
PMID: 30182202
Biophys Rev. 2018 Oct;10(5):1377-1384. doi: 10.1007/s12551-018-0450-3. Epub 2018 Sep 04.

Mechanical stimuli acting on the cellular membrane are linked to intracellular signaling events and downstream effectors via different mechanoreceptors. Mechanosensitive (MS) ion channels are the fastest known primary mechano-electrical transducers, which convert mechanical stimuli into meaningful intracellular signals on...

Cite
Martinac B, Bavi N, Ridone P, et al. Tuning ion channel mechanosensitivity by asymmetry of the transbilayer pressure profile. Biophys Rev. 2018;10(5):1377-1384doi: 10.1007/s12551-018-0450-3.
Martinac, B., Bavi, N., Ridone, P., Nikolaev, Y. A., Martinac, A. D., Nakayama, Y., Rohde, P. R., & Bavi, O. (2018). Tuning ion channel mechanosensitivity by asymmetry of the transbilayer pressure profile. Biophysical reviews, 10(5), 1377-1384. https://doi.org/10.1007/s12551-018-0450-3
Martinac, Boris, et al. "Tuning ion channel mechanosensitivity by asymmetry of the transbilayer pressure profile." Biophysical reviews vol. 10,5 (2018): 1377-1384. doi: https://doi.org/10.1007/s12551-018-0450-3
Martinac B, Bavi N, Ridone P, Nikolaev YA, Martinac AD, Nakayama Y, Rohde PR, Bavi O. Tuning ion channel mechanosensitivity by asymmetry of the transbilayer pressure profile. Biophys Rev. 2018 Oct;10(5):1377-1384. doi: 10.1007/s12551-018-0450-3. Epub 2018 Sep 04. PMID: 30182202; PMCID: PMC6233343.
Copy Download .nbib Format: NLM
Factor XI gene variants in factor XI-deficient patients of Southern Italy: identification of a novel mutation and genotype-phenotype relationship.

Human genome variation

Tiscia GL, Favuzzi G, Lupone MR, Cappucci F, Schiavulli M, Mirabelli V, D'Andrea G, Chinni E, Giuliani N, Caliandro R, Grandone E.
PMID: 29138690
Hum Genome Var. 2017 Nov 09;4:17043. doi: 10.1038/hgv.2017.43. eCollection 2017.

Congenital Factor XI (FXI) deficiency shows a high variability in clinical phenotype. To date, many allele variants have been shown to cause this bleeding disorder. However, the genotype-phenotype relationship is difficult to establish. This report provides insights into this...

Cite
Tiscia GL, Favuzzi G, Lupone MR, et al. Factor XI gene variants in factor XI-deficient patients of Southern Italy: identification of a novel mutation and genotype-phenotype relationship. Hum Genome Var. 2017;4:17043doi: 10.1038/hgv.2017.43.
Tiscia, G. L., Favuzzi, G., Lupone, M. R., Cappucci, F., Schiavulli, M., Mirabelli, V., D'Andrea, G., Chinni, E., Giuliani, N., Caliandro, R., & Grandone, E. (2017). Factor XI gene variants in factor XI-deficient patients of Southern Italy: identification of a novel mutation and genotype-phenotype relationship. Human genome variation, 417043. https://doi.org/10.1038/hgv.2017.43
Tiscia, Giovanni L, et al. "Factor XI gene variants in factor XI-deficient patients of Southern Italy: identification of a novel mutation and genotype-phenotype relationship." Human genome variation vol. 4 (2017): 17043. doi: https://doi.org/10.1038/hgv.2017.43
Tiscia GL, Favuzzi G, Lupone MR, Cappucci F, Schiavulli M, Mirabelli V, D'Andrea G, Chinni E, Giuliani N, Caliandro R, Grandone E. Factor XI gene variants in factor XI-deficient patients of Southern Italy: identification of a novel mutation and genotype-phenotype relationship. Hum Genome Var. 2017 Nov 09;4:17043. doi: 10.1038/hgv.2017.43. eCollection 2017. PMID: 29138690; PMCID: PMC5678205.
Copy Download .nbib Format: NLM
Thrombotic microangiopathy, DIC-syndrome and COVID-19: link with pregnancy prothrombotic state.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians

Makatsariya AD, Slukhanchuk EV, Bitsadze VO, Khizroeva JKH, Tretyakova MV, Tsibizova VI, Elalamy I, Gris JC, Grandone E, Makatsariya NA, Mashkova T.
PMID: 32627622
J Matern Fetal Neonatal Med. 2020 Jul 06;1-9. doi: 10.1080/14767058.2020.1786811. Epub 2020 Jul 06.

For last months, humanity has faced a formidable unknown enemy, which is presented as a new coronavirus infection. Despite the fact that the causative agents of new diseases appear at a certain frequency and that the virus SARS-CoV-2 has...

Cite
Makatsariya AD, Slukhanchuk EV, Bitsadze VO, et al. Thrombotic microangiopathy, DIC-syndrome and COVID-19: link with pregnancy prothrombotic state. J Matern Fetal Neonatal Med. 2020;1-9doi: 10.1080/14767058.2020.1786811.
Makatsariya, A. D., Slukhanchuk, E. V., Bitsadze, V. O., Khizroeva, J. K. H., Tretyakova, M. V., Tsibizova, V. I., Elalamy, I., Gris, J. C., Grandone, E., Makatsariya, N. A., & Mashkova, T. (2020). Thrombotic microangiopathy, DIC-syndrome and COVID-19: link with pregnancy prothrombotic state. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 1-9. https://doi.org/10.1080/14767058.2020.1786811
Makatsariya, A D, et al. "Thrombotic microangiopathy, DIC-syndrome and COVID-19: link with pregnancy prothrombotic state." The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians vol. (2020): 1-9. doi: https://doi.org/10.1080/14767058.2020.1786811
Makatsariya AD, Slukhanchuk EV, Bitsadze VO, Khizroeva JKH, Tretyakova MV, Tsibizova VI, Elalamy I, Gris JC, Grandone E, Makatsariya NA, Mashkova T. Thrombotic microangiopathy, DIC-syndrome and COVID-19: link with pregnancy prothrombotic state. J Matern Fetal Neonatal Med. 2020 Jul 06;1-9. doi: 10.1080/14767058.2020.1786811. Epub 2020 Jul 06. PMID: 32627622.
Copy Download .nbib Format: NLM
Managing Cardiovascular Risk in Type 2 Diabetes: What Do the Cardiovascular Outcome Trials Mean for Australian Practice?.

Diabetes therapy : research, treatment and education of diabetes and related disorders

Deed G, Atherton JJ, d'Emden M, Rasalam R, Sharma A, Sindone A.
PMID: 31292928
Diabetes Ther. 2019 Oct;10(5):1625-1643. doi: 10.1007/s13300-019-0663-x. Epub 2019 Jul 10.

Understanding the implications of cardiovascular (CV) outcomes data of glucose-lowering agents on the management of type 2 diabetes mellitus can be challenging for many primary practitioners. Amongst different classes of diabetes medications assessed for CV safety, several agents within...

Cite
Deed G, Atherton JJ, d'Emden M, et al. Managing Cardiovascular Risk in Type 2 Diabetes: What Do the Cardiovascular Outcome Trials Mean for Australian Practice?. Diabetes Ther. 2019;10(5):1625-1643doi: 10.1007/s13300-019-0663-x.
Deed, G., Atherton, J. J., d'Emden, M., Rasalam, R., Sharma, A., & Sindone, A. (2019). Managing Cardiovascular Risk in Type 2 Diabetes: What Do the Cardiovascular Outcome Trials Mean for Australian Practice?. Diabetes therapy : research, treatment and education of diabetes and related disorders, 10(5), 1625-1643. https://doi.org/10.1007/s13300-019-0663-x
Deed, Gary, et al. "Managing Cardiovascular Risk in Type 2 Diabetes: What Do the Cardiovascular Outcome Trials Mean for Australian Practice?." Diabetes therapy : research, treatment and education of diabetes and related disorders vol. 10,5 (2019): 1625-1643. doi: https://doi.org/10.1007/s13300-019-0663-x
Deed G, Atherton JJ, d'Emden M, Rasalam R, Sharma A, Sindone A. Managing Cardiovascular Risk in Type 2 Diabetes: What Do the Cardiovascular Outcome Trials Mean for Australian Practice?. Diabetes Ther. 2019 Oct;10(5):1625-1643. doi: 10.1007/s13300-019-0663-x. Epub 2019 Jul 10. PMID: 31292928; PMCID: PMC6778570.
Copy Download .nbib Format: NLM
Binding of DNA origami to lipids: maximizing yield and switching via strand displacement.

Nucleic acids research

Singh JKD, Darley E, Ridone P, Gaston JP, Abbas A, Wickham SFJ, Baker MAB.
PMID: 34614184
Nucleic Acids Res. 2021 Nov 08;49(19):10835-10850. doi: 10.1093/nar/gkab888.

Liposomes are widely used as synthetic analogues of cell membranes and for drug delivery. Lipid-binding DNA nanostructures can modify the shape, porosity and reactivity of liposomes, mediated by cholesterol modifications. DNA nanostructures can also be designed to switch conformations...

Cite
Singh JKD, Darley E, Ridone P, et al. Binding of DNA origami to lipids: maximizing yield and switching via strand displacement. Nucleic Acids Res. 2021;49(19):10835-10850doi: 10.1093/nar/gkab888.
Singh, J. K. D., Darley, E., Ridone, P., Gaston, J. P., Abbas, A., Wickham, S. F. J., & Baker, M. A. B. (2021). Binding of DNA origami to lipids: maximizing yield and switching via strand displacement. Nucleic acids research, 49(19), 10835-10850. https://doi.org/10.1093/nar/gkab888
Singh, Jasleen Kaur Daljit, et al. "Binding of DNA origami to lipids: maximizing yield and switching via strand displacement." Nucleic acids research vol. 49,19 (2021): 10835-10850. doi: https://doi.org/10.1093/nar/gkab888
Singh JKD, Darley E, Ridone P, Gaston JP, Abbas A, Wickham SFJ, Baker MAB. Binding of DNA origami to lipids: maximizing yield and switching via strand displacement. Nucleic Acids Res. 2021 Nov 08;49(19):10835-10850. doi: 10.1093/nar/gkab888. PMID: 34614184; PMCID: PMC8565350.
Copy Download .nbib Format: NLM
Focus on Key Issues in Immune Thrombotic Thrombocytopenic Purpura: Italian Experience of Six Centers.

Journal of clinical medicine

Tiscia G, Sartori MT, Giuffrida G, Ostuni A, Cascavilla N, Nicolosi D, Battista C, Santeramo TM, Melillo L, Giordano G, Cappucci F, Fischetti L, Chinni E, Tarantini G, Cerbo A, Bertomoro A, Fabris F, Grandone E.
PMID: 34884404
J Clin Med. 2021 Dec 04;10(23). doi: 10.3390/jcm10235702.

Immune-mediated thrombotic thrombocytopenic purpura is a rare and challenging hematological disease caused by the antibody anti-ADAMTS13. Though the mortality rate has decreased considerably in recent years, fatalities still remain unacceptable. This study aimed at further adding to the existing...

Cite
Tiscia G, Sartori MT, Giuffrida G, et al. Focus on Key Issues in Immune Thrombotic Thrombocytopenic Purpura: Italian Experience of Six Centers. J Clin Med. 2021;10(23)doi: 10.3390/jcm10235702.
Tiscia, G., Sartori, M. T., Giuffrida, G., Ostuni, A., Cascavilla, N., Nicolosi, D., Battista, C., Santeramo, T. M., Melillo, L., Giordano, G., Cappucci, F., Fischetti, L., Chinni, E., Tarantini, G., Cerbo, A., Bertomoro, A., Fabris, F., & Grandone, E. (2021). Focus on Key Issues in Immune Thrombotic Thrombocytopenic Purpura: Italian Experience of Six Centers. Journal of clinical medicine, 10(23), . https://doi.org/10.3390/jcm10235702
Tiscia, Giovanni, et al. "Focus on Key Issues in Immune Thrombotic Thrombocytopenic Purpura: Italian Experience of Six Centers." Journal of clinical medicine vol. 10,23 (2021). doi: https://doi.org/10.3390/jcm10235702
Tiscia G, Sartori MT, Giuffrida G, Ostuni A, Cascavilla N, Nicolosi D, Battista C, Santeramo TM, Melillo L, Giordano G, Cappucci F, Fischetti L, Chinni E, Tarantini G, Cerbo A, Bertomoro A, Fabris F, Grandone E. Focus on Key Issues in Immune Thrombotic Thrombocytopenic Purpura: Italian Experience of Six Centers. J Clin Med. 2021 Dec 04;10(23). doi: 10.3390/jcm10235702. PMID: 34884404.
Copy Download .nbib Format: NLM
Caspases and therapeutic potential of caspase inhibitors in moderate-severe SARS CoV2 infection and long COVID.

Allergy

Plassmeyer M, Alpan O, Corley MJ, Premeaux TA, Lillard K, Coatney P, Vaziri T, Michalsky S, Pang APS, Bukhari Z, Yeung ST, Evering TH, Naughton G, Latterich M, Mudd P, Spada A, Rindone N, Loizou D, Ulrik Sønder S, Ndhlovu LC, Gupta R.
PMID: 33993490
Allergy. 2021 May 15; doi: 10.1111/all.14907. Epub 2021 May 15.

BACKGROUND: COVID-19 can present with lymphopenia and extraordinary complex multiorgan pathologies that can trigger long-term sequela.AIMS: Given that inflammasome products, like caspase-1, play a role in the pathophysiology of a number of co-morbid conditions, we investigated caspases across the...

Cite
Plassmeyer M, Alpan O, Corley MJ, et al. Caspases and therapeutic potential of caspase inhibitors in moderate-severe SARS CoV2 infection and long COVID. Allergy. 2021;doi: 10.1111/all.14907.
Plassmeyer, M., Alpan, O., Corley, M. J., Premeaux, T. A., Lillard, K., Coatney, P., Vaziri, T., Michalsky, S., Pang, A. P. S., Bukhari, Z., Yeung, S. T., Evering, T. H., Naughton, G., Latterich, M., Mudd, P., Spada, A., Rindone, N., Loizou, D., Ulrik Sønder, S., Ndhlovu, L. C., & Gupta, R. (2021). Caspases and therapeutic potential of caspase inhibitors in moderate-severe SARS CoV2 infection and long COVID. Allergy, . https://doi.org/10.1111/all.14907
Plassmeyer, Matthew, et al. "Caspases and therapeutic potential of caspase inhibitors in moderate-severe SARS CoV2 infection and long COVID." Allergy vol. (2021). doi: https://doi.org/10.1111/all.14907
Plassmeyer M, Alpan O, Corley MJ, Premeaux TA, Lillard K, Coatney P, Vaziri T, Michalsky S, Pang APS, Bukhari Z, Yeung ST, Evering TH, Naughton G, Latterich M, Mudd P, Spada A, Rindone N, Loizou D, Ulrik Sønder S, Ndhlovu LC, Gupta R. Caspases and therapeutic potential of caspase inhibitors in moderate-severe SARS CoV2 infection and long COVID. Allergy. 2021 May 15; doi: 10.1111/all.14907. Epub 2021 May 15. PMID: 33993490; PMCID: PMC8222863.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 88 entries